First published clinical trial using live biotherapeutic candidate in Covid-19 patients suggests role in improving outcomes
Blenrep (belantamab mafodotin) plus BorDex showed statistically significant progression-free survival (PFS) benefit versus daratumumab plus BorDex
Gene therapy AB-1005 being developed to locally increase glial cell line-derived neurotrophic factor (GDNF) levels
This approval showcases Teva’s proven strengths in complex generic formulations development and device engineering
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Total transaction value of the divestment is Rs. 3,660 million
NATCO's Pharmacovigilance Department was inspected from October 30, 2023 to November 1, 2023
Impressive safety and efficacy for solid cancer patients followed by global clinical study plan
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Subscribe To Our Newsletter & Stay Updated
